查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1770812

全球兒茶素市場規模（按類型、來源、功能和應用）—區域展望、競爭策略、2034 年細分市場預測

Catechin Market Size - By Type, By Source, By Function, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年全球兒茶素市場規模將達到 2,761 萬美元，複合年成長率為 3.66%。

限制因素：兒茶素市場面臨許多重大挑戰，可能阻礙其成長。主要問題是提取和加工成本高昂。由於溶劑萃取和層析法精製等先進製程所需的高能耗和複雜的基礎設施，導致生產成本增加。這種定價障礙可能會限制兒茶素產品的可得性，尤其是在消費者重視價格的地區。此外，複雜的監管也構成了一項重大挑戰。

本報告研究了全球兒茶素市場，並提供了區域市場規模預測、促進因素、限制因素、機會、挑戰分析和公司概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 促進因素、限制因素、機會與挑戰分析
    • 驅動程式
    • 限制因素
    • 機會
    • 任務

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭態勢

  • 全球兒茶素市場：製造地、銷售區域與介面類型分佈
  • 全球兒茶素市場的併購、夥伴關係、介面推出和聯盟

第7章 全球兒茶素市場規模（按類型）（2021-2034）

  • 表兒茶素
  • 表兒茶素沒食子酸酯（ECG）
  • 表沒食子兒茶素（EGC）
  • 表沒食子兒茶素沒食子酸酯 (EGCG)
  • 其他

第8章 全球兒茶素市場規模（依來源）（2021-2034）

  • 綠茶兒茶素
  • 可可兒茶素
  • 葡萄兒茶素
  • 其他

第9章 全球兒茶素市場規模（依功能）（2021-2034）

  • 抗氧化劑
  • 心血管健康
  • 體重管理
  • 皮膚健康
  • 消炎（藥）
  • 大腦健康
  • 其他

第 10 章 全球兒茶素市場規模（依應用） （2021-2034）

  • 機能性食品
  • 機能飲料
  • 化妝品、護膚
  • 營養補充品
  • 其他

第 11 章全球兒茶素市場規模（2021-2034）

  • 全球兒茶素市場規模與市場佔有率

第 12 章 依地區分類的全球兒茶素市場規模（2021-2034 年）

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他中東和非洲地區
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他拉丁美洲

第13章 公司簡介

  • Biosynth
  • Botaniex
  • Caymanchem
  • Hangzhou Qinyuan Natural Plant Technology
  • Indena
  • INDOFINE Chemical Company
  • Novanat Bioresources
  • Taiyo
  • Tata Chemicals Limited
  • Vital-Chem
  • 其他

第14章 結論

第 15 章簡稱表

第 16 章參考鏈接

簡介目錄
Product Code: FOOD2567

Catechin Market Introduction and Overview

According to SPER Market Research, 'Global Catechin Market Size - By Type, By Source, By Function, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Catechin Market is predicted to reach 27.61 million by 2034 with a CAGR of 3.66%.

A naturally occurring component of plants, catechin belongs to the flavonoid family, specifically the flavan-3-ols subgroup. This type of antioxidant is well known for its health-promoting properties and is found in the highest concentration in green tea, chocolate, berries, and apples. Because they help the body combat harmful free radicals, catechins help reduce oxidative stress and inflammation. Epicatechin, epicatechin gallate, epigallocatechin, and epigallocatechin gallate (EGCG) are polyphenolic chemicals that come in a variety of stereoisomeric forms.

Restraints: There are several major challenges facing the catechins market that could hinder its growth. A major issue is the significant expense associated with extraction and processing. Production costs are increased by the high energy consumption and complex infrastructure required for advanced processes like solvent-based extraction and chromatographic purification. This pricing barrier may limit the availability of catechin products, especially in areas where consumers are price-sensitive. Regulatory complexity also presents significant challenges.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type, By Source, By Function, By Application

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Biosynth, Botaniex, Caymanchem, Hangzhou Qinyuan Natural Plant Technology, Indena, INDOFINE Chemical Company, Novanat Bioresources, Taiyo, Tata Chemicals Limited, Vital-Chem.

Global Catechin Market Segmentation:

By Type: Based on the Type, Global Catechin Market is segmented as; Epicatechin, Epicatechin gallate (ECG), Epigallocatechin (EGC), Epigallocatechin gallate (EGCG), Others.

By Source: Based on the Source, Global Catechin Market is segmented as; Green tea catechins, Cocoa catechins, Grape catechins, Others.

By Function: Based on the Function, Global Catechin Market is segmented as; Antioxidants, Cardiovascular health, Weight management, Skin health, Anti-inflammatory, Brain health, Others.

By Application: Based on the Application, Global Catechin Market is segmented as; Functional foods, Functional beverages, Cosmetics and skincare, Nutraceuticals, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Catechin Market Manufacturing Base Distribution, Sales Area, Interface Type
  • 6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Catechin Market

7. Global Catechin Market, By Type 2021-2034 (USD Million)

  • 7.1. Epicatechin
  • 7.2. Epicatechin gallate (ECG)
  • 7.3. Epigallocatechin (EGC)
  • 7.4. Epigallocatechin gallate (EGCG)
  • 7.5. Others

8. Global Catechin Market, By Source 2021-2034 (USD Million)

  • 8.1. Green tea catechins
  • 8.2. Cocoa catechins
  • 8.3. Grape catechins
  • 8.4. Others

9. Global Catechin Market, By Function 2021-2034 (USD Million)

  • 9.1. Antioxidants
  • 9.2. Cardiovascular health
  • 9.3. Weight management
  • 9.4. Skin health
  • 9.5. Anti-inflammatory
  • 9.6. Brain health
  • 9.7. Others

10. Global Catechin Market, By Application 2021-2034 (USD Million)

  • 10.1. Functional foods
  • 10.2. Functional beverages
  • 10.3. Cosmetics and skincare
  • 10.4. Nutraceuticals
  • 10.5. Others

11. Global Catechin Market, 2021-2034 (USD Million)

  • 11.1. Global Catechin Market Size and Market Share

12. Global Catechin Market, By Region, 2021-2034 (USD Million)

  • 12.1. Asia-Pacific
    • 12.1.1. Australia
    • 12.1.2. China
    • 12.1.3. India
    • 12.1.4. Japan
    • 12.1.5. South Korea
    • 12.1.6. Rest of Asia-Pacific
  • 12.2. Europe
    • 12.2.1. France
    • 12.2.2. Germany
    • 12.2.3. Italy
    • 12.2.4. Spain
    • 12.2.5. United Kingdom
    • 12.2.6. Rest of Europe
  • 12.3. Middle East and Africa
    • 12.3.1. Kingdom of Saudi Arabia
    • 12.3.2. United Arab Emirates
    • 12.3.3. Qatar
    • 12.3.4. South Africa
    • 12.3.5. Egypt
    • 12.3.6. Morocco
    • 12.3.7. Nigeria
    • 12.3.8. Rest of Middle-East and Africa
  • 12.4. North America
    • 12.4.1. Canada
    • 12.4.2. Mexico
    • 12.4.3. United States
  • 12.5. Latin America
    • 12.5.1. Argentina
    • 12.5.2. Brazil
    • 12.5.3. Rest of Latin America

13. Company Profile

  • 13.1. Biosynth
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Interface summary
    • 13.1.4. Recent developments
  • 13.2. Botaniex
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Interface summary
    • 13.2.4. Recent developments
  • 13.3. Caymanchem
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Interface summary
    • 13.3.4. Recent developments
  • 13.4. Hangzhou Qinyuan Natural Plant Technology
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Interface summary
    • 13.4.4. Recent developments
  • 13.5. Indena
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Interface summary
    • 13.5.4. Recent developments
  • 13.6. INDOFINE Chemical Company
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Interface summary
    • 13.6.4. Recent developments
  • 13.7. Novanat Bioresources
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Interface summary
    • 13.7.4. Recent developments
  • 13.8. Taiyo
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Interface summary
    • 13.8.4. Recent developments
  • 13.9. Tata Chemicals Limited
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Interface summary
    • 13.9.4. Recent developments
  • 13.10. Vital-Chem
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Interface summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links